Lotus Pharmaceuticals, Inc. (LTUS)

OTCMKTS · Delayed Price · Currency is USD

0.0036

0.00 (0.00%)

At close: Apr 6, 2026

-34.55% (1Y)

Market Cap	9.52M
Revenue (ttm)	71.39M
Net Income (ttm)	1.72M
Shares Out	2.64B
EPS (ttm)	0.06
PE Ratio	0.06
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,900
Average Volume	18,174
Open	0.0036
Previous Close	0.0036
Day's Range	0.0036 - 0.0036
52-Week Range	0.0025 - 0.0111
Beta	-1.80
RSI	47.20
Earnings Date	n/a

About Lotus Pharmaceuticals

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People’s Republic of China. The company was formerly known as S.E. Asia Trading, Inc. and changed its name to Lotus Pharmaceuticals, Inc. in December 2006. Lotus Pharmaceuticals, Inc. is based in Irvine, California. [Read more]

Industry Shell Companies

Sector Financials

CEO Zhong Yi Liu

Employees 533

Stock Exchange OTCMKTS

Ticker Symbol LTUS

Full Company Profile

Financial Performance

In 2010, Lotus Pharmaceuticals's revenue was $72.70 million, an increase of 28.71% compared to the previous year's $56.48 million. Earnings were $14.42 million, a decrease of -12.22%.

News

There is no news available yet.